BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29610160)

  • 1. The Use of Pyridostigmine in a Child With Chronic Intestinal Pseudo-Obstruction.
    Choudhury A; Rahyead A; Kammermeier J; Mutalib M
    Pediatrics; 2018 Apr; 141(Suppl 5):S404-S407. PubMed ID: 29610160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Pyridostigmine in Pediatric Gastrointestinal Motility Disorders: A Case Series.
    Manini ML; Camilleri M; Grothe R; Di Lorenzo C
    Paediatr Drugs; 2018 Apr; 20(2):173-180. PubMed ID: 29243034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyridostigmine in chronic intestinal pseudo-obstruction - a systematic review.
    Wilkie BD; Noori J; Johnston M; Woods R; Keck JO; Behrenbruch C
    ANZ J Surg; 2023 Sep; 93(9):2086-2091. PubMed ID: 37132128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic intestinal pseudo-obstruction.
    Sadjadpour K
    Mayo Clin Proc; 1989 Jun; 64(6):728. PubMed ID: 2747296
    [No Abstract]   [Full Text] [Related]  

  • 5. Prokinetics in the treatment of acute intestinal pseudo-obstruction.
    De Giorgio R; Stanghellini V; Barbara G; Guerrini S; Lioce A; Vasina V; Tonini M; Cola B; Corinaldesi R; De Ponti F
    IDrugs; 2004 Feb; 7(2):160-5. PubMed ID: 15057661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine.
    O'Dea CJ; Brookes JH; Wattchow DA
    Colorectal Dis; 2010 Jun; 12(6):540-8. PubMed ID: 19508545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal pseudo-obstruction in myotonic dystrophy.
    Brunner HG; Hamel BC; Rieu P; Höweler CJ; Peters FT
    J Med Genet; 1992 Nov; 29(11):791-3. PubMed ID: 1453429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intestinal pseudo-obstruction].
    Heilmann G; Erckenbrecht JF
    Ther Umsch; 1994 Mar; 51(3):208-15. PubMed ID: 8160167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Pyridostigmine-responsive Visceral Myopathy With ACTG2 Mutations: A Case Series.
    Lee H; Park S; Oh JT; Kim HM; Kim S; Lee JS
    J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):e16-e17. PubMed ID: 30334933
    [No Abstract]   [Full Text] [Related]  

  • 10. Cisapride in the treatment of chronic intestinal pseudo-obstruction.
    Reyntjens A; Verlinden M; Schuermans V
    Z Gastroenterol; 1990 Apr; 28 Suppl 1():79-84; discussion 92-3. PubMed ID: 2192509
    [No Abstract]   [Full Text] [Related]  

  • 11. Pyridostigmine in Pediatric Intestinal Pseudo-obstruction: Case Report of a 2-year Old Girl and Literature Review.
    Di Nardo G; Viscogliosi F; Esposito F; Stanghellini V; Villa MP; Parisi P; Morlando A; Caló G; De Giorgio R
    J Neurogastroenterol Motil; 2019 Oct; 25(4):508-514. PubMed ID: 31587541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative quantitative assessment of global small bowel motility using magnetic resonance imaging in chronic intestinal pseudo-obstruction and healthy controls.
    Menys A; Butt S; Emmanuel A; Plumb AA; Fikree A; Knowles C; Atkinson D; Zarate N; Halligan S; Taylor SA
    Neurogastroenterol Motil; 2016 Mar; 28(3):376-83. PubMed ID: 26661570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of prucalopride in treatment of chronic constipation and recurrent functional obstruction in a patient with steinert myotonic dystrophy.
    Giglio MC; Luglio G; Tarquini R; Cerbone D; Bucci P; Bucci L
    J Clin Gastroenterol; 2015 Jan; 49(1):85-6. PubMed ID: 24804990
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of pyridostigmine on small intestinal bacterial overgrowth (SIBO) and plasma inflammatory biomarkers in HIV-associated autonomic neuropathies.
    Robinson-Papp J; Nmashie A; Pedowitz E; George MC; Sharma S; Murray J; Benn EKT; Lawrence SA; Machac J; Heiba S; Kim-Schulze S; Navis A; Roland BC; Morgello S
    J Neurovirol; 2019 Aug; 25(4):551-559. PubMed ID: 31098925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical recovery of chronic intestinal pseudo-obstruction with cisapride in a complex pediatric patient.
    Cameron JC; Vaillancourt R; Major-Cook N; Boland M; Zucker M; Lariviere D
    Am J Hosp Palliat Care; 2013 Jun; 30(4):403-5. PubMed ID: 22964344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antroduodenal motility in children with chronic intestinal pseudo-obstruction.
    Hyman PE; McDiarmid SV; Napolitano J; Abrams CE; Tomomasa T
    J Pediatr; 1988 Jun; 112(6):899-905. PubMed ID: 3373394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colonic manometry in children with chronic intestinal pseudo-obstruction.
    Di Lorenzo C; Flores AF; Reddy SN; Snape WJ; Bazzocchi G; Hyman PE
    Gut; 1993 Jun; 34(6):803-7. PubMed ID: 8314513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal pseudoobstruction as a feature of myotonic muscular dystrophy.
    Füger K; Barnert J; Höpfner W; Wienbeck M
    Z Gastroenterol; 1995 Sep; 33(9):534-8. PubMed ID: 8525657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute on chronic intestinal pseudoobstruction responds to neostigmine.
    Borgaonkar MR; Lumb B
    Dig Dis Sci; 2000 Aug; 45(8):1644-7. PubMed ID: 11007118
    [No Abstract]   [Full Text] [Related]  

  • 20. Pseudo-obstruction in children.
    Peck SN; Altschuler SM
    Gastroenterol Nurs; 1992 Feb; 14(4):184-8. PubMed ID: 1377952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.